In clear cell renal cell carcinoma, RNF43 can inhibit malignant behavior and reverse pazopanib resistance by inhibiting the YAP signaling by decreasing YAP phosphorylation via p-LATS1/2 [59]. Here, LATS1 is linked to clear cell renal carcinoma.